Clinical Trial Update: ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease

View source ↗

Summary

Completed clinical trial evaluating the ST2 biomarker for cardiac remodeling in adults with congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Congenital Heart Disease | Status: COMPLETED